Researcher
Rik
- Keywords:Medicine
- Disciplines:Hematology
Affiliations
- Hematology (Department)
Member
From1 Jul 2012 → Today - Hematology (Research group)
Member
From1 Oct 2003 → Today - Clinical sciences (Department)
Member
From8 Apr 2019 → Today - Clinical sciences (Department)
Member
From1 Jan 2014 → 20 Oct 2022 - Laboratory of Molecullar and Cellular Therapy (Research group)
Member
From28 Feb 2013 → 1 Oct 2019 - Immunology and Microbiology (Department)
Member
From1 Dec 2006 → 31 Dec 2013 - Immunology and Microbiology (Department)
Member
From1 Dec 2003 → 30 Sep 2006
Publications
21 - 30 of 56
- Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma(2016)
Authors: Philippe Moreau, Tamas Masszi, Norbert Grzasko, Nizar J Bahlis, Markus Hansson, Ludek Pour, Irwindeep Sandhu, Peter Ganly, Bartrum W Baker, Sharon R Jackson, et al.
Pages: 1621-1634 - Impact of renal impairment on outcomes with lenalidomide and dexamethasone treatment in the FIRST trial, a randomized, open-label phase 3 trial in transplant-ineligible patients with multiple myeloma(2016)
Authors: Meletios A Dimopoulos, Matthew C Cheung, Murielle Roussel, Ting Liu, Barbara Gamberi, Brigitte Kolb, H Guenter Derigs, HyeonSeok Eom, Karim Belhadj, Pascal Lenain, et al.
Pages: 363-70 - Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR)(2016)
Authors: Meletios A Dimopoulos, Philippe Moreau, Antonio Palumbo, Douglas Joshua, Ludek Pour, Roman Hajek, Thierry Facon, Heinz Ludwig, Albert Oriol, Hartmut Goldschmidt, et al.
Pages: 27-38 - Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma(2015)
Authors: A. Keith Stewart, S. Vincent Rajkumar, Meletios A Dimopoulos, Tamas Masszi, Ivan Spicka, Albert Oriol, Roman Hajek, Laura Rosiñol, David S. Siegel, Georgi G. Mihaylov, et al.
Pages: 142-152 - Immunomodulatory drugs improve the immune environment for dendritic cell-based immunotherapy in multiple myeloma patients after autologous stem cell transplantation(2014)
Authors: Brenda De Keersmaecker, Karel Fostier, Jurgen Corthals, Sofie Wilgenhof, Carlo Heirman, Joeri L Aerts, Kris Thielemans, Henri Schots
Pages: 1023-1036 - Cellular immunotherapy in multiple myeloma: Lessons from preclinical models(2014)
Authors: Marilene Binsfeld, Karel Fostier, J. Muller, F. Baron, Henri Schots, Yves Beguin, R Heusschen, Jo Caers
Pages: 392-404 - Preclinical evaluation of invariant natural killer T cells in the 5T33 multiple myeloma model(2013)
Authors: Haneen Nur, Karel Fostier, Sandrine Aspeslagh, Wim Renmans, Elisabeth Bertrand, Xavier Leleu, Mérédis Favreau, Karine Breckpot, Henri Schots, Marc De Waele, et al.
- Diagnostic potential of CD34+ cell antigen expression in myelodysplastic syndromes(2012)
Authors: Dieter De Smet, Fabienne Trullemans, Kristin Jochmans, Wim Renmans, Lut Smet, Olivier Heylen, A.m. Bael, Henri Schots, Barbara Leus, Marc De Waele
Pages: 732-743 - Expansion of polyfunctional HIV-specific T cells upon stimulation with mRNA electroporated dendritic cells in the presence of immunomodulatory drugs(2012)
Authors: Brenda De Keersmaecker, Sabine D Allard, P Lacor, Henri Schots, Kris Thielemans, Joeri L Aerts
Pages: 9351-9360 - Suspected "t-cell-mediated" hypereosinophilic syndrome presenting with cerebral watershed infarcts(2011)
Authors: S Dujardin, Henri Schots, Sylvie De Raedt